Search research articles
Contact Us
Filters
Showing results (121-130 of 158) with videos related to
Page
of 16
Sort By:
Journal of Internal Medicine
|
September 22, 2025
Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort study
Shogo Matsuda, Takuya Kotani, Daisuke Nishioka, et al.
Modern Rheumatology
|
December 12, 2025
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: a multicentre REVEAL cohort study
Hirofumi Miyake, Ayana Okazaki, Shogo Matsuda, et al.
BMC Rheumatology
|
May 14, 2026
Personalized exercise therapy during targeted drug therapy tapering in patients with rheumatoid arthritis: a pilot randomized controlled trial
Shinsuke Yamada, Akira Onishi, Takumi Imai, et al.
Modern Rheumatology
|
December 15, 2021
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study
Koichi Murata, Ryuji Uozumi, Motomu Hashimoto, et al.
Arthritis Research & Therapy
|
March 7, 2025
Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study
Akira Onishi, Masao Tanaka, Takayuki Fujii, et al.
Modern Rheumatology
|
June 10, 2023
Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus
Yuri Nishida, Mirei Shirakashi, Noritaka Hashii, et al.
Arthritis Research & Therapy
|
March 28, 2021
Urinary sodium-to-potassium ratio associates with hypertension and current disease activity in patients with rheumatoid arthritis: a cross-sectional study
Hiroto Minamino, Masao Katsushima, Motomu Hashimoto, et al.
Rheumatology (Oxford, England)
|
September 9, 2024
Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus
Masao Katsushima, Yoichi Nakayama, Tsuneyasu Yoshida, et al.
Modern Rheumatology
|
September 16, 2022
Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis
Ryu Watanabe, Megumi Oshima, Norihiro Nishioka, et al.
Modern Rheumatology
|
January 21, 2023
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort
Tomoya Nakajima, Hiroshi Doi, Ryu Watanabe, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 158) with videos related to
Sort By:
Page
of 16
Journal of Internal Medicine
|
September 22, 2025
Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort study
Shogo Matsuda, Takuya Kotani, Daisuke Nishioka, et al.
Modern Rheumatology
|
December 12, 2025
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: a multicentre REVEAL cohort study
Hirofumi Miyake, Ayana Okazaki, Shogo Matsuda, et al.
BMC Rheumatology
|
May 14, 2026
Personalized exercise therapy during targeted drug therapy tapering in patients with rheumatoid arthritis: a pilot randomized controlled trial
Shinsuke Yamada, Akira Onishi, Takumi Imai, et al.
Modern Rheumatology
|
December 15, 2021
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study
Koichi Murata, Ryuji Uozumi, Motomu Hashimoto, et al.
Arthritis Research & Therapy
|
March 7, 2025
Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study
Akira Onishi, Masao Tanaka, Takayuki Fujii, et al.
Modern Rheumatology
|
June 10, 2023
Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus
Yuri Nishida, Mirei Shirakashi, Noritaka Hashii, et al.
Arthritis Research & Therapy
|
March 28, 2021
Urinary sodium-to-potassium ratio associates with hypertension and current disease activity in patients with rheumatoid arthritis: a cross-sectional study
Hiroto Minamino, Masao Katsushima, Motomu Hashimoto, et al.
Rheumatology (Oxford, England)
|
September 9, 2024
Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus
Masao Katsushima, Yoichi Nakayama, Tsuneyasu Yoshida, et al.
Modern Rheumatology
|
September 16, 2022
Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis
Ryu Watanabe, Megumi Oshima, Norihiro Nishioka, et al.
Modern Rheumatology
|
January 21, 2023
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort
Tomoya Nakajima, Hiroshi Doi, Ryu Watanabe, et al.
Page
of 16